Orbia Advance Corporation, S.A.B. de C.V. Unsponsored ADR (OTCMKTS:MXCHY - Get Free Report) traded down 13% during trading on Friday . The company traded as low as $1.31 and last traded at $1.31. 1,900 shares traded hands during mid-day trading, a decline of 46% from the average session volume of 3,544 shares. The stock had previously closed at $1.51.
Analyst Ratings Changes
Separately, Barclays reaffirmed an "overweight" rating on shares of Orbia Advance in a report on Tuesday, May 6th.
Get Our Latest Analysis on Orbia Advance
Orbia Advance Trading Up 1.6%
The company's 50 day simple moving average is $1.36 and its two-hundred day simple moving average is $1.39. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.36 and a quick ratio of 0.93.
Orbia Advance Company Profile
(
Get Free Report)
Orbia Advance Corporation, SAB. de C.V. provides products and solutions for precision agriculture, building and infrastructure, fluorinated, polymer, and connectivity sectors worldwide. The company offers irrigation systems, agricultural and greenhouse projects, digital farming technologies, and related services; and connectivity solutions, including conduits, cable-in conduit, and other HDPE products and solutions.
See Also
Before you consider Orbia Advance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Orbia Advance wasn't on the list.
While Orbia Advance currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.